The Board of Directors of Bursa Malaysia Berhad (“Bursa Malaysia”) wishes to announce the following:

(i) Bursa Malaysia will acquire the remaining 25% equity interest in Bursa Malaysia Derivatives Berhad (“Bursa Derivatives”) from CME Group Strategic Investments LLC (“CMEGSI”) consequent to an exercise of a put option (“Put Option”) by CME Group Inc (“CME Group”) (“the Acquisition”). Upon completion of the Acquisition, Bursa Derivatives becomes a wholly-owned subsidiary of Bursa Malaysia.

(ii) On 18 September 2019, Bursa Derivatives entered into an agreement with Chicago Mercantile Exchange Inc and CMEG Strategic Sdn Bhd (collectively referred to as “CME”) to vary the terms of the existing Globex Services Agreement (“GSA”). Bursa Derivatives also entered into a non-binding Strategic Cooperation Agreement (“SCA”) with CME, signifying CME's commitment to the Malaysian derivatives market under which CME and Bursa Derivatives will explore new products and other business opportunities that will deliver value to their respective customers.

The details of the Proposals are as set out in the attached Announcement dated 18 September 2019. The media release on the same is also attached.